Neroshield, Inc. — Form D/A

Neroshield, Inc. of Bradenton, FL, a company, filed a Form D amendment with the SEC on 2023-12-12. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other Technology.

Offering

Filed: 2023-12-12
Form: D/A
Accession: 0001952549-23-000001
Industry: Other Technology
Exemptions: 06b
Total offering: $2.5M
Amount sold: $2.5M
Investors: 21
Date of first sale: 2022-10-18
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-463306

Issuer

Name: Neroshield, Inc.
CIK: 0001952549
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 7466 Cortez Rd West, Bradenton, FL, 34210
Phone: 1-888-711-1381

Officers, directors & promoters (8)

Name	Role	Location
Chester Aldridge	Director	Bradenton, FL
David Maloney	Executive Officer	New York, NY
Daniel Stammen	Director	Bradenton, FL
Daniel Stammen	Executive Officer	Bradenton, FL
Corey Cole	Director	Bradenton, FL
Corey Cole	Executive Officer	Bradenton, FL
Jordan Ziriada	Director	Bradenton, FL
Jordan Ziriada	Executive Officer	Bradenton, FL

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2025-05-28	D/A	$9.0M	$5.8M
2022-11-02	D/A	$2.0M	$150K
2022-10-31	D	$2.0M	$300K

More